Presentation is loading. Please wait.

Presentation is loading. Please wait.

Γ-Aminobutyric Acid (A) Receptor Agonists Accelerate Cutaneous Barrier Recovery and Prevent Epidermal Hyperplasia Induced by Barrier Disruption  Mitsuhiro.

Published byIngrid Hovland Modified over 5 years ago

Similar presentations

Presentation on theme: "Γ-Aminobutyric Acid (A) Receptor Agonists Accelerate Cutaneous Barrier Recovery and Prevent Epidermal Hyperplasia Induced by Barrier Disruption  Mitsuhiro."— Presentation transcript:

1 γ-Aminobutyric Acid (A) Receptor Agonists Accelerate Cutaneous Barrier Recovery and Prevent Epidermal Hyperplasia Induced by Barrier Disruption  Mitsuhiro Denda, PhD, Kaori Inoue, Shinji Inomata, Sumiko Denda  Journal of Investigative Dermatology  Volume 119, Issue 5, Pages (November 2002) DOI: /j x Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

2 Figure 1 GABA and GABA(A)-type receptor agonists, muscimol and isoguvacine, accelerated barrier repair. On the other hand, the GABA(B)-type receptor agonist, baclofen, did not affect the barrier recovery rate. The same tendency was observed at 1, 3, and 6 h after the treatment. Vertical axes show the recovery percentage of each measurement time point to the level to the original level. Error bars show SD of each average. F= , p<0.001, Two points were measured in one flank skin and four to eight animals were used for each treatment. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

3 Figure 2 The effect of GABA was blocked by the GABA(A)-type receptor antagonist, bicuculline methobromide, but GABA(B)-type receptor antagonist, saclofen, did not block the effect of GABA application. Topical application of bicuculline methobromide or saclofen alone did not affect the barrier recovery rate. The same tendency was observed at 1, 3, and 6 h after the treatment. Vertical axes show the recovery percentage of each measurement time point to the level to the original level. Error bars show SD of each average. F= , p<0.001, Two points were measured in one flank skin and four to six animals were used for each treatment. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

4 Figure 3 Topical application of GABA prevented the epidermal hyperplasia induced by acetone treatment under low environmental humidity. (A–D) Dark spots show BrdU-positive cells. (A) Shows the hyperproliferative epidermis treated with water after the acetone treatment under the low humidity. Topical application of 1 mM GABA prevented the epidermal hyperplasia (B). The effect of GABA was blocked by bicucullin methobromide (C). The increase was seen on the epidermal basal layer (A). (D) Shows the untreated control. Bars=20 μm. The quantified results of the epidermal thickness are shown in (E). The topical application of GABA significantly reduced the epidermal thickness and it was blocked by bicucullin methobromide. The number of BrdU-positive cells in the epidermis of each treatment (F) shows the same tendency as in (E). Error bars show SD of each average. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

5 Figure 4 Immunoreactivity against GABA(A) receptor polyclonal antibody was observed in the hairless mouse epidermis (A, green color). Merged image with Nomarski microscopic observation and DAPI staining (blue color) is shown in (B). The immunoreactivity against the GABA antibody was blocked by a blocking peptide: (C) merged image with DAPI, and (D) Nomarski. Bars=20 μm. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

6 Figure 5 The fluorescent GABA(A) probe shows localization of the GABA(A) receptor in the nucleated layer of the hairless mouse epidermis: (A) red color, merged image with DAPI, and (B) Nomarski microscopic observation. It was reduced by preincubation with bicucullin methobromide: (C) merged image with DAPI, and (D) Nomarski. Bars=20 μm. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

7 Figure 6 There was a significant decrease in MEQ fluorescence (i.e., elevation in intracellular chloride ion concentration) in cultured human keratinocytes treated with 10 μMGABA. The decrease was completely blocked by 10 μM bicucullin methobromide. One hundred keratinocytes were evaluated for each treatment. The vertical axis shows the ratio of the fluorescence after 5 min incubation to those before the treatment. Mean±SD: blank, 0.894±0.044; GABA, 0.814±0.048; GABA and BMB, 0.908± F=85.086, p<0.0001, One hundreds cells were measured for each treatment. Journal of Investigative Dermatology  , DOI: ( /j x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Download ppt "Γ-Aminobutyric Acid (A) Receptor Agonists Accelerate Cutaneous Barrier Recovery and Prevent Epidermal Hyperplasia Induced by Barrier Disruption  Mitsuhiro."

Similar presentations

Nan-Hyung Kim, Ai-Young Lee  Journal of Investigative Dermatology 

Nan-Hyung Kim, Ai-Young Lee  Journal of Investigative Dermatology 
Low Humidity Stimulates Epidermal DNA Synthesis and Amplifies the Hyperproliferative Response to Barrier Disruption: Implication for Seasonal Exacerbations.

Low Humidity Stimulates Epidermal DNA Synthesis and Amplifies the Hyperproliferative Response to Barrier Disruption: Implication for Seasonal Exacerbations.
Exogenous Smad3 Accelerates Wound Healing in a Rabbit Dermal Ulcer Model  Koji Sumiyoshi, Atsuhito Nakao, Yasuhiro Setoguchi, Ko Okumura, Hideoki Ogawa 

Exogenous Smad3 Accelerates Wound Healing in a Rabbit Dermal Ulcer Model  Koji Sumiyoshi, Atsuhito Nakao, Yasuhiro Setoguchi, Ko Okumura, Hideoki Ogawa 
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress- Induced Skin Damage  Rhonda M. Brand, Michael W. Epperly, J. Mark Stottlemyer,

A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress- Induced Skin Damage  Rhonda M. Brand, Michael W. Epperly, J. Mark Stottlemyer,
Negative Electric Potential Induces Alteration of Ion Gradient and Lamellar Body Secretion in the Epidermis, and Accelerates Skin Barrier Recovery After.

Negative Electric Potential Induces Alteration of Ion Gradient and Lamellar Body Secretion in the Epidermis, and Accelerates Skin Barrier Recovery After.
Hee-Young Park, PhD, Jin Lee, Sameer Kapasi, Shaun Peterson, Barbara A

Hee-Young Park, PhD, Jin Lee, Sameer Kapasi, Shaun Peterson, Barbara A
Topical Application of 17β-Estradiol Increases Extracellular Matrix Protein Synthesis by Stimulating TGF-β Signaling in Aged Human Skin In Vivo  Eui Dong.

Topical Application of 17β-Estradiol Increases Extracellular Matrix Protein Synthesis by Stimulating TGF-β Signaling in Aged Human Skin In Vivo  Eui Dong.
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.

Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
Ryanodine Receptors Are Expressed in Epidermal Keratinocytes and Associated with Keratinocyte Differentiation and Epidermal Permeability Barrier Homeostasis 

Ryanodine Receptors Are Expressed in Epidermal Keratinocytes and Associated with Keratinocyte Differentiation and Epidermal Permeability Barrier Homeostasis 
Dopamine D2-Like Receptor Agonists Accelerate Barrier Repair and Inhibit the Epidermal Hyperplasia Induced by Barrier Disruption  Shigeyoshi Fuziwara,

Dopamine D2-Like Receptor Agonists Accelerate Barrier Repair and Inhibit the Epidermal Hyperplasia Induced by Barrier Disruption  Shigeyoshi Fuziwara,
Ectodysplasin A Pathway Contributes to Human and Murine Skin Repair

Ectodysplasin A Pathway Contributes to Human and Murine Skin Repair
An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the PAR-2 Pathway  Christine Paine, Elizabeth Sharlow, Frank Liebel, Magdalena.

An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the PAR-2 Pathway  Christine Paine, Elizabeth Sharlow, Frank Liebel, Magdalena.
Calcium Ion Gradients and Dynamics in Cultured Skin Slices of Rat Hindpaw in Response to Stimulation with ATP  Moe Tsutsumi, Sumiko Denda, Kaori Inoue,

Calcium Ion Gradients and Dynamics in Cultured Skin Slices of Rat Hindpaw in Response to Stimulation with ATP  Moe Tsutsumi, Sumiko Denda, Kaori Inoue,
Anna Celli, Debra Crumrine, Jason M. Meyer, Theodora M. Mauro 

Anna Celli, Debra Crumrine, Jason M. Meyer, Theodora M. Mauro 
Rachid Sougrat, R. Gobin, Jean-Marc Verbavatz 

Rachid Sougrat, R. Gobin, Jean-Marc Verbavatz 
Rottlerin, a Specific Inhibitor of Protein Kinase C-delta, Impedes Barrier Repair Response by Increasing Intracellular Free Calcium  Bong K. Ahn, Se K.

Rottlerin, a Specific Inhibitor of Protein Kinase C-delta, Impedes Barrier Repair Response by Increasing Intracellular Free Calcium  Bong K. Ahn, Se K.
Enhancing 1α-Hydroxylase Activity with the 25-Hydroxyvitamin D-1α-Hydroxylase Gene in Cultured Human Keratinocytes and Mouse Skin  Tai C. Chen, Xue Hong.

Enhancing 1α-Hydroxylase Activity with the 25-Hydroxyvitamin D-1α-Hydroxylase Gene in Cultured Human Keratinocytes and Mouse Skin  Tai C. Chen, Xue Hong.
Mite and Cockroach Allergens Activate Protease-Activated Receptor 2 and Delay Epidermal Permeability Barrier Recovery  Se Kyoo Jeong, Hyun Jeong Kim,

Mite and Cockroach Allergens Activate Protease-Activated Receptor 2 and Delay Epidermal Permeability Barrier Recovery  Se Kyoo Jeong, Hyun Jeong Kim,
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,

Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,
Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.

Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.

Similar presentations

Ads by Google